Evidence map›Paper›PMID 39927418›Full record

ArticleDiabetes, obesity & metabolism2025

Adding social determinants of health to the equation: Development of a cardiometabolic disease staging model using clinical and social determinants of health to predict type 2 diabetes.

Carrie R Howell, Shiori Tanaka, Li Zhang, April P Carson, Nengjun Yi, James M Shikany, W Timothy Garvey, Andrea L Cherrington

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carrie R HowellDivision of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-6554-6237
Shiori TanakaDivision of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Li ZhangDepartment of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
April P CarsonDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Nengjun YiDepartment of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
James M ShikanyDivision of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
W Timothy GarveyDepartment of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Andrea L CherringtonDivision of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
VCID and Stroke in a Bi-racial National CohortU01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CUSHMAN, MARY, HOWARD, GEORGE · 2002 to 2022
$96.0M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC)75N92023D00002 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, JING · 2023 to 2025
$6.8M
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - OAKLAND FIELD CENTER75N92023D00003 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BHATT, ANKEET S. · 2023 to 2025
$2.2M
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - BIRMINGHAM FIELD CENTER75N92023D00005 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA · 2023 to 2025
$2.2M
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - CHICAGO FIELD CENTERDIVERSITY SUPPLEMENT FOR MORGANN WEST75N92023D00004 · NHLBI · NORTHWESTERN UNIVERSITY · PI CARNETHON, MERCEDES · 2023 to 2025
$2.1M
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - UNIVERSITY OF MINNESOTA FIELD CENTER.75N92023D00006 · NHLBI · UNIVERSITY OF MINNESOTA · PI SCHREINER, PAMELA J · 2023 to 2025
$1.7M
Harnessing social determinant of health data to identify and engage high risk, socially vulnerable populations for diabetes preventionK01MD017270 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HOWELL, CARRIE R. · 2022 to 2025
$513k
CORONARY ARTERY DISEASE RISK DEVELOPMENT IN YOUNG ADULTS-N01HC95095-268095095N01HC095095 · HC · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, DALE · 1989 to 2006
$376k
American Heart Association-American Stroke Association 931540NCI NIH HHS P30 CA006927NHLBI NIH HHS 75N92023D00002NHLBI NIH HHS 75N92023D00003NHLBI NIH HHS 75N92023D00004NHLBI NIH HHS 75N92023D00005NHLBI NIH HHS 75N92023D00006NHLBI NIH HHS N01 HC095095NIDDK NIH HHS P30 DK079626NIMHD NIH HHS 1K01 MD0172706NIMHD NIH HHS K01 MD017270NINDS NIH HHS U01 NS041588
6 · The paper itself

Abstract

aimsIdentifying individuals at the highest risk of progression to type 2 diabetes (T2D) using clinical and social determinants of health (SDoH) measures will help prioritize prevention efforts. We aimed to investigate model performance after adding SDoH to a previously validated cardiometabolic disease staging diabetes risk prediction model. MATERIALS AND

methodsWe developed a Bayesian predictive model using data [clinical factors: fasting glucose, blood pressure, body mass index, high-density lipoprotein cholesterol, triglycerides; individual SDoH: income, education, health insurance status, relationship status, self-reported stress and neighbourhood SDoH: census-tract level social vulnerability index] from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study to predict T2D with external validation using the Coronary Artery Risk Development in Young Adults (CARDIA) study.

resultsThe analysis included 9907 REGARDS participants without T2D at baseline [mean age 63 years (SD 8.5), 54% female, 33% non-Hispanic Black] who completed a follow-up visit 10 years later. N = 1268 (12.8%) developed T2D. Adding SDoH to the clinical model modestly improved performance [Area Under the Curve: 0.802 vs. 0.804, p = 0.01]. Calibration plots indicated that the clinical model underpredicted risk in disadvantaged SDoH subgroups, whereas the clinical plus SDoH model improved prediction accuracy in subgroups. Classification tables revealed that the clinical plus SDoH model accurately reclassified individuals categorized as borderline risk in a clinical-only model.

conclusionIncluding SDoH in T2D risk prediction and stratification at the population level may aid in better classifying T2D risk among vulnerable populations, which has important implications for screening strategies.

Indexed as

Diabetes Mellitus, Type 2Social Determinants of HealthAgedBayes TheoremBody Mass IndexCardiometabolic Risk FactorsDisease ProgressionFemaleHumansMaleMiddle AgedRisk AssessmentRisk Factorscardiometabolic diseaserisk predictionrisk stratificationsocial determinants of healthtype 2 diabetes

Identifiers

PMID39927418
PMCPMC11964832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.